Concepedia

Anil Sajjala

AS

Statistics

Publications

3

Citations

36

H-Index

3

Active since

2019

Affiliations

Autifony Therapeutics (United Kingdom)(Current)

King's College London

University College London

Imperial College London

Anil Sajjala is an author at Autifony Therapeutics (United Kingdom) specializing in medicine, magnetic resonance imaging, and neurology.

Top concepts

Publications per year

2019–2022

3

Publications

3

The effect of AUT00206, a Kv3 potassium channel modulator, on dopamine synthesis capacity and the reliability of [<sup>18</sup>F]-FDOPA imaging in schizophrenia

Ilinca Angelescu, Stephen J. Kaar, Tiago Reis Marques et al. · Journal of Psychopharmacology · 2022 · 13 citations · Full text

T108. AUT00206, A NOVEL KV3 CHANNEL MODULATOR, REDUCES KETAMINE-INDUCED BOLD SIGNALLING IN HEALTHY MALE VOLUNTEERS: A RANDOMISED PLACEBO-CONTROLLED CROSSOVER TRIAL

Francesca Perini, Jadwiga Nazimek, Shane McKie et al. · Schizophrenia Bulletin · 2019 · 12 citations · Full text

, , +20

The effects of AUT00206, a novel Kv3.1/3.2 potassium channel modulator, on task-based reward system activation: a test of mechanism in schizophrenia

Stephen J. Kaar, Ilinca Angelescu, Matthew M. Nour et al. · Psychopharmacology · 2022 · 11 citations · Full text

1–3 of 3